BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 20590864)

  • 1. Mild haemophilia: a disease with many faces and many unexpected pitfalls.
    Peerlinck K; Jacquemin M
    Haemophilia; 2010 Jul; 16 Suppl 5():100-6. PubMed ID: 20590864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation.
    Hay CR; Ludlam CA; Colvin BT; Hill FG; Preston FE; Wasseem N; Bagnall R; Peake IR; Berntorp E; Mauser Bunschoten EP; Fijnvandraat K; Kasper CK; White G; Santagostino E
    Thromb Haemost; 1998 Apr; 79(4):762-6. PubMed ID: 9569189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmopressin for the treatment of haemophilia.
    Castaman G
    Haemophilia; 2008 Jan; 14 Suppl 1():15-20. PubMed ID: 18173690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors in mild/moderate haemophilia A: an update.
    Franchini M; Salvagno GL; Lippi G
    Thromb Haemost; 2006 Aug; 96(2):113-8. PubMed ID: 16894451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype.
    Seary ME; Feldman D; Carcao MD
    Haemophilia; 2012 Jan; 18(1):50-5. PubMed ID: 21592259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to desmopressin of factors XI, X and V in patients with factor VIII deficiency and von Willebrand disease.
    White B; Lawler P; Riddell A; Nitu-Whalley IC; Hermans C; Lee CA; Brown SA
    Br J Haematol; 2004 Jul; 126(1):100-4. PubMed ID: 15198739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmopressin is not always effective in mild haemophilia A patients undergoing urological surgery: the need of standardized protocols.
    Renom P; Wibaut B; Rigot JM; Coupez B; Goudemand J
    Haemophilia; 2002 Sep; 8(5):711-4. PubMed ID: 12199685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of inhibitor development in mild haemophilia A increases with age.
    Mauser-Bunschoten EP; Den Uijl IE; Schutgens RE; Roosendaal G; Fischer K
    Haemophilia; 2012 Mar; 18(2):263-7. PubMed ID: 21851507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of factor VIII (FVIII) inhibitor in haemophilia A.
    Borhany M; Kumari M; Shamsi T; Naz A; Farzana T
    J Coll Physicians Surg Pak; 2012 May; 22(5):289-93. PubMed ID: 22538032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmopressin in mild hemophilia A: indications, limitations, efficacy, and safety.
    Lethagen S
    Semin Thromb Hemost; 2003 Feb; 29(1):101-6. PubMed ID: 12640572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors to factor VIII in a family with mild hemophilia: molecular characterization and response to factor VIII and desmopressin.
    Santagostino E; Gringeri A; Tagliavacca L; Mannucci PM
    Thromb Haemost; 1995 Aug; 74(2):619-21. PubMed ID: 8584995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the understanding of acquired haemophilia A: implications for clinical practice.
    Collins PW; Percy CL
    Br J Haematol; 2010 Jan; 148(2):183-94. PubMed ID: 19814739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmopressin--a haemostatic drug: state-of-the-art review.
    Lethagen S
    Eur J Anaesthesiol Suppl; 1997 Mar; 14():1-9. PubMed ID: 9088828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful eradication of a FVIII inhibitor in a 60-year-old patient with mild haemophilia A using single-agent prednisolone.
    Holstein K; Marx G; Lentz B; Bokemeyer C; Langer F
    Hamostaseologie; 2012; 32 Suppl 1():S48-51. PubMed ID: 22960877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Options for treating acute bleeds in addition to bypassing agents: extracorporeal immunoadsorption, FVIII/FIX, desmopressin and antifibrinolytics.
    Berntorp E
    Haemophilia; 2006 Dec; 12 Suppl 6():62-5; discussion 65-6. PubMed ID: 17123396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical issues in inhibitors.
    Astermark J; Santagostino E; Keith Hoots W
    Haemophilia; 2010 Jul; 16 Suppl 5():54-60. PubMed ID: 20590857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of mild haemophilia: a 30-year single centre experience.
    Tagliaferri A; Di Perna C; Riccardi F; Pattacini C; Rivolta GF; Franchini M
    Haemophilia; 2012 Mar; 18(2):166-74. PubMed ID: 21771207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New assays for monitoring haemophilia treatment.
    Shima M; Matsumoto T; Ogiwara K
    Haemophilia; 2008 Jul; 14 Suppl 3():83-92. PubMed ID: 18510527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acquired hemophilia: current status in Japan and immuno-biochemical features of autoantibodies to factor VIII].
    Tanaka I; Shima N
    Rinsho Ketsueki; 2005 Feb; 46(2):91-8. PubMed ID: 16447701
    [No Abstract]   [Full Text] [Related]  

  • 20. How I manage patients with acquired haemophilia A.
    Sborov DW; Rodgers GM
    Br J Haematol; 2013 Apr; 161(2):157-65. PubMed ID: 23373521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.